Abstract
The most common cause of obliterative disease in limb arteries is slowly progressive arteriosclerosis which is eventually superimposed by thrombosis.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
J. Hirsh and E. Genton, Thrombogenesis, in: “Physiological Pharmacology,” W.S. Root and N.L. Berlin, eds., Academic Press, New York (1974), pp. 99–133.
H.L. Nossel, M. Ti, K.L. Kaplan, K. Spanondis, T. Soland, and V.P. Butler, Jr., The generation of fibrinopeptide A in clinical blood samples, J. Clin. Invest., 58: 1136 (1976).
A.I. Schäfer and R.I. Handin, The role of platelets in thrombotic and vascular disease, Prog. Cardiovasc. Dis., 22: 31 (1979).
J.F. Mustard and M.A. Packham, The role of blood and platelets in atherosclerosis and the complications of atherosclerosis, Thromb. Diath. Haemorrh., 33: 444 (1975).
K.W.E. Denson, in: “Human Blood Coagulation, Haemostasis and Thrombosis,” R. Biggs, ed., Blackwell Scienfic Publication, Oxford-Edinburgh (1976).
C.B. Laurell, Electroimmunoassay, Scand. J. Clin. Lab. Invest., 29 Suppl. 124: 21 (1972).
H.J. Weiss, L.W. Hoyer, R.F. Rickles, A. Varma, and J. Rogers, Quantitative assay of a plasma factor deficient of von Willebrand disease that is necessary for platelet aggregation: relationship to decreased F. VIII procoagulant activity and antigen content, J. Clin. Invest., 52: 2708 (1973).
P.N. Walsh, Platelet coagulant activities and haemostasis: a hypothesis, Blood, 43: 597 (1974).
E. Von Kaulla and K.N. Von Kaulla, Antithrombin III and disease, Am. J. Clin. Pathol., 48: 69 (1967).
G. Avellone, V. Mandalà, F. Riolo, and A. Pinto, AT III in patients with atherosclerotic disease, in: “Vascular Occlusion: Epidemiological, Pathophysiological, and Therapeutic Aspects,” Serono Symp. 37, M. Tesi and J. Dormandy, eds., Academic Press, New York, (1981), pp. 193–197.
G. Avellone, G. Davì, A. Pinto, and V. Mandalà, L’antitrombina III nella cardiopatia ischemica, Boll. Sic., XXIV, 2, 127-133 (1979).
G. Davì, G.B. Rini, M. Averna, S. Novo, G. Di Fede, A. Mattina, A. Notarbartolo, and A. Strano, Enhanced platelet release reaction in insulin-dependent and insulin-independent diabetic patients, Haemostasis, 12: 275–281 (1982).
G. Davì, S. Novo, A. Pinto, N. Custro, M. Averna, A. Mattina, and A. Strano, Platelet activation after adrenergic stimulation in hypertensive patients: effects of acebutolol, Eur. Heart J., 4: 295–299 (1983).
A. Strano, G. Davit, M. Averna, G.B. Rini, S. Novo, G. Di Fede, A. Mattina, and A. Notarbartolo, Platelet sensitivity to prostacyclin and thromboxane production in hyperlipidemic patients, Thromb. Haemost., 48: 18–20 (1982).
A. Strano, G. Davì, M. Traina, S. Novo, and A. Ranieri, Thromboxane formation by platelets and platelet sensitivity to prostacyclin in patients with acute myocardial infarction, Thromb. Haemost., 46: 759 (1981).
G. Davì, G.B. Rini, M. Averna, S. Novo, G. Di Fede, A. Pinto, A. Notarbartolo, and A. Strano, Thromboxane B2 formation and platelet sensitivity to prostacyclin in insulin-dependent and insulin-independent diabetics, Thromb. Res., 26: 359–370 (1982).
K.K. Wu and J.C. Hoak, A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency, Lancet, 2: 924 (1974).
A. Strano, S. Novo, G. Davì, G. Avellone, and A. Pinto, Platelet aggregation coagulation and fibrinolysis at rest and after bicycle ergometer test in CHD, in: “Selected Topics in Exercise Cardiology and Rehabilitation,” A. Raineri, J.J. Kellermann, and V. Rulli, eds., Plenum Press, London, (1980). pp. 265–276.
A. Strano, S. Novo, G. Davì, G. Avellone, and V. Mandalà, Effects of sorbinicate and nicotinic acid on blood viscosity, red cell deformation and platelet function, Pharm. Res. Comm., 14: 639–648 (1982).
G. Davì, G.B. Rini, M. Averna, S. Novo, G. Di Fede, A. Mattina, M. Fiore, and A. Notarbartolo, Misurazione del tempo di rigenerazione piastrinica in pazienti dislipidemici, Rassegna di Medicina Interna, 3: 41–46 (1982).
H.C. Kwaan, J.A. Colwell, S. Cruz, N. Suwanwella, and J.G. Dobbie, Increased platelet aggregation in diabetes mellitus, J. Lab. Clin. Med., 80: 236–246 (1972).
M.M. Bern, M.P. Cassani, J. Horton, L. Rand, and G. Davis, Changes in fibrinolysis and factor VIII coagulant, antigen, and ristocetin cofactor in diabetes mellitus and atherosclerosis, Thromb. Res., 19: 831–839 (1980).
G. Cella, J. Zahavi, H.A. de Haas, and V.V. Kakkar, β-thrombo-globulin, platelet production time, and platelet function in vascular disease, Br. J. Haematol., 43: 127–136 (1979).
G. Baele, H. Bogaerts, D.L. Clement, R. Pannier, and F. Barbier, Platelet activation during treadmill exercise in patients with chronic peripheral arterial disease, Thromb. Res., 23: 215 (1981).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Plenum Press, New York
About this chapter
Cite this chapter
Strano, A., Davì, G., Avellone, G., Novo, S., Pinto, A. (1985). Hemostatic Alterations in Peripheral Arteriopathies. In: Cajozzo, A., Perricone, R., Di Marco, P., Palazzolo, P. (eds) Advances in Hemostasis and Thrombosis. Ettore Majorana International Science Series, vol 20. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-9424-6_20
Download citation
DOI: https://doi.org/10.1007/978-1-4615-9424-6_20
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-9426-0
Online ISBN: 978-1-4615-9424-6
eBook Packages: Springer Book Archive